Related Experiment Video
Updated: Jul 31, 2026
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
The rationale for combination therapy
1Mycology Reference Centre, Division of Microbiology, University of Leeds, UK. e.g.v.evans@leeds.ac.uk
Abstract:
Fungal infections of the nail are common in European populations. There are a number of clinical presentations usually resulting from an infection by one of the dermatophyte species, notably Trichophyton rubrum. A number of modern treatment strategies are available and are generally well tolerated and effective. However, a significant proportion of patients, 20-30%, can expect treatment failure and/or relapse following treatment. The search for new treatment modalities and drugs is hampered by our lack of understanding of the basic pathophysiological mechanisms that underlie these frequently encountered infections. A correct diagnosis is key to the implementation of successful treatment. Even then, some infections do appear to be more recalcitrant than others. This may be the result of a number of interacting factors: patient susceptibility, fungal growth patterns that resist treatment and the occurrence of dormant fungal spores (arthrospores) in the nail. Increasingly, research is turning towards the identification of clinical indicators of poor prognosis and the development of new treatment strategies to overcome them. The combination of drugs to produce synergistic activity is one possible advance towards achieving higher cure rates.
Insights
Nail fungal infections, often caused by Trichophyton rubrum, frequently resist treatment. Understanding underlying mechanisms and identifying poor prognostic indicators are crucial for developing new therapies to improve cure rates.
Area of Science:
- Mycology
- Dermatology
- Infectious Diseases
Background:
- Fungal nail infections are prevalent in Europe, commonly caused by dermatophytes like Trichophyton rubrum.
- Current treatments are often effective but have a significant failure or relapse rate (20-30%).
- Limited understanding of nail fungal infection pathophysiology hinders the development of novel therapeutic strategies.
Purpose of the Study:
- To highlight the challenges in treating fungal nail infections.
- To emphasize the need for better diagnostic and prognostic tools.
- To explore potential advancements in treatment modalities.
Main Methods:
- Review of current literature on fungal nail infections.
- Analysis of factors contributing to treatment resistance.
- Discussion of emerging research directions.
Main Results:
- Treatment failure and relapse rates remain high despite available therapies.
- Patient susceptibility, fungal resistance, and dormant spores (arthrospores) contribute to recalcitrant infections.
- Research is focusing on identifying poor prognostic indicators and synergistic drug combinations.
Conclusions:
- Accurate diagnosis is essential for effective treatment of fungal nail infections.
- Further research into pathophysiological mechanisms is needed to overcome treatment resistance.
- Developing new strategies, such as combination therapies, may improve cure rates for difficult-to-treat cases.
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Combined Effects of Drugs: Synergism
Such synergistic combinations...
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
01:28Drug Therapy
Antianxiety Medications